Ton Lisman Selected Research

Ton Lisman Research Topics

Disease

55	Fibrosis (Cirrhosis) 03/2024 - 03/2002
54	Liver Diseases (Liver Disease) 04/2024 - 07/2006
52	Hemorrhage 04/2024 - 03/2002
37	Thrombosis (Thrombus) 01/2023 - 03/2006
9	Thrombocytopenia (Thrombopenia) 10/2022 - 02/2008
9	Thrombophilia 01/2022 - 02/2005
8	Acute-On-Chronic Liver Failure 12/2023 - 09/2020
8	Inflammation (Inflammations) 05/2023 - 07/2009
8	Acute Liver Failure (Fulminant Hepatic Failure) 01/2023 - 06/2010
8	End Stage Liver Disease 01/2023 - 01/2007
8	COVID-19 10/2021 - 10/2020
7	Hemophilia A (Haemophilia) 04/2024 - 01/2002
7	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021 - 05/2007
6	Portal Hypertension 12/2023 - 01/2007
5	Neoplasms (Cancer) 05/2023 - 09/2004
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 03/2007
5	Pathologic Constriction (Stenosis) 01/2015 - 08/2011
4	Venous Thromboembolism 10/2023 - 07/2008
4	Wounds and Injuries (Trauma) 04/2023 - 03/2017
4	Hepatic Encephalopathy 03/2022 - 04/2016
4	Myocardial Infarction 10/2021 - 06/2009
4	Reperfusion Injury 09/2021 - 08/2012
4	Ischemia 01/2019 - 08/2011
4	Non-alcoholic Fatty Liver Disease 02/2017 - 01/2015
3	Chronic Kidney Failure (Chronic Renal Failure) 05/2024 - 01/2019
3	Fatty Liver 11/2023 - 09/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 11/2007
3	Sepsis (Septicemia) 10/2023 - 06/2010
3	von Willebrand Diseases (von Willebrand's Disease) 05/2023 - 03/2007
3	Leg Injuries (Leg Injury) 04/2023 - 01/2022
3	Liver Failure 01/2023 - 08/2010
3	Disease Progression 01/2022 - 01/2015
3	Critical Illness (Critically Ill) 01/2022 - 01/2021
3	Disease Susceptibility (Diathesis) 01/2014 - 03/2002
3	Thrombasthenia (Glanzmann Thrombasthenia) 04/2008 - 03/2003
2	Brain Death (Brain Dead) 02/2024 - 01/2022
2	Atrial Fibrillation 09/2023 - 01/2023
2	Thrombotic Microangiopathies 05/2023 - 01/2015
2	Thromboembolism 05/2023 - 01/2014
2	Necrosis 01/2023 - 01/2019
2	Pulmonary Embolism 10/2021 - 08/2004
2	Disseminated Intravascular Coagulation 01/2019 - 03/2017
2	Obesity 11/2016 - 06/2016

Drug/Important Bio-Agent (IBA)

63	Hemostatics (Antihemorrhagics)IBA 04/2024 - 07/2006
39	AnticoagulantsIBA 03/2024 - 03/2006
27	Thrombin FDA Link 04/2023 - 04/2008
22	von Willebrand FactorIBA 12/2023 - 07/2006
18	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2006
12	Heparin (Liquaemin)FDA LinkGeneric 10/2021 - 08/2004
11	Fibrinogen (Factor I)FDA Link 11/2023 - 06/2016
10	FibrinIBA 11/2023 - 05/2007
9	recombinant FVIIa (rFVIIa)FDA Link 11/2020 - 01/2002
8	Blood Coagulation Factors (Coagulation Factor)IBA 04/2024 - 07/2008
8	fibrin fragment D (D-dimer)IBA 01/2023 - 01/2017
8	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 08/2004
7	AntigensIBA 12/2023 - 07/2006
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2023 - 08/2005
7	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2023 - 01/2002
7	Factor VIII (Coagulation Factor VIII)IBA 05/2022 - 06/2010
6	Prothrombin (Factor II)IBA 06/2023 - 07/2013
6	PlasminogenIBA 01/2023 - 05/2007
6	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023 - 06/2008
6	ThrombomodulinIBA 01/2022 - 08/2005
5	AntithrombinsIBA 01/2023 - 12/2013
5	Thromboplastin (Tissue Factor)IBA 07/2022 - 09/2004
5	nasIBA 01/2015 - 08/2011
4	Plasminogen Activator Inhibitor 1IBA 01/2023 - 07/2009
4	Fibrinolysin FDA Link 01/2023 - 01/2015
3	edoxabanIBA 03/2024 - 01/2020
3	Factor XIII (Coagulation Factor XIII)IBA 11/2023 - 09/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2019
3	Vitamin K FDA Link 01/2022 - 01/2019
3	Oral ContraceptivesIBA 01/2022 - 05/2008
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2017 - 05/2007
3	CollagenIBA 06/2010 - 07/2006
2	Dabigatran FDA Link 03/2024 - 01/2014
2	apixabanIBA 03/2024 - 04/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2023 - 07/2013
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2023 - 01/2020
2	Protein CIBA 01/2023 - 01/2023
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2023 - 09/2013
2	Factor VIIa (Activated Factor VII)IBA 01/2023 - 04/2008
2	Protein SIBA 01/2023 - 09/2013
2	AutoantibodiesIBA 05/2022 - 02/2021
2	Thiobarbituric Acid Reactive SubstancesIBA 01/2022 - 09/2019
2	Cell-Free Nucleic AcidsIBA 01/2022 - 09/2019
2	dicarboxydine (DCD)IBA 01/2022 - 10/2015
2	ThrombospondinsIBA 01/2021 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2015

Therapy/Procedure

36	Liver Transplantation 11/2023 - 03/2002
17	Therapeutics 10/2023 - 07/2013
10	Transplantation 05/2024 - 08/2013
6	Hepatectomy 11/2023 - 01/2015
4	Kidney Transplantation 05/2024 - 01/2018
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2021 - 07/2008
2	Contraindications 10/2022 - 11/2021
2	Critical Care (Surgical Intensive Care) 03/2022 - 07/2019
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 04/2016